Synthesis and pharmacokinetic profile of rhein- boswellic acid conjugate
Dhaneshwar Suneela, Patil Dipmala
Index: Bioorg. Med. Chem. Lett. 22(24) , 7582-7, (2012)
Full Text: HTML
Abstract
A novel gastro-sparing prodrug of rhein and boswellic acid was designed for the management of osteoarthritis and its synthesis, characterization and pharmacokinetic profile is reported. The prodrug was activated by hydrolysis releasing rhein (91%) and boswellic acid (84.37%) in rat blood over a period of 7h upon its oral administration.
Related Compounds
Related Articles:
Factors affecting formulation characteristics and stability of ascorbic acid in water-in-oil creams.
2014-10-01
[Int. J. Cosmet. Sci. 36(5) , 494-504, (2014)]
2015-11-01
[J. Colloid. Interface Sci. 457 , 298-306, (2015)]
Antioxidants in heat-processed koji and the production mechanisms.
2015-11-15
[Food Chem. 187 , 364-9, (2015)]
Electrochemical vapor deposition of semiconductors from gas phase with a solid membrane cell.
2015-05-27
[J. Am. Chem. Soc. 137 , 6638-42, (2015)]
Influence of genetic polymorphism on t,t-MA/S-PMA ratio in 301 benzene exposed subjects.
2014-12-01
[Toxicol. Lett. 231(2) , 205-12, (2014)]